Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Altered Insulin Signaling in Alzheimer’s Disease Brain – Special Emphasis on PI3K-Akt Pathway
Sami Gabbouj, Simo Ryhänen, Mikael Marttinen, et al.
Frontiers in Neuroscience (2019) Vol. 13
Open Access | Times Cited: 318

Showing 26-50 of 318 citing articles:

The role of PI3K/Akt signalling pathway in spinal cord injury
Chun-Lin Xiao, Wenchao Yin, Yanchun Zhong, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 156, pp. 113881-113881
Closed Access | Times Cited: 50
High frequency repetitive transcranial magnetic stimulation alleviates cognitive deficits in 3xTg-AD mice by modulating the PI3K/Akt/GLT-1 axis
Huấn Cao, Chengchao Zuo, Zhongya Gu, et al.
Redox Biology (2022) Vol. 54, pp. 102354-102354
Open Access | Times Cited: 49
Vanillin-based functionalization strategy to construct multifunctional microspheres for treating inflammation and regenerating intervertebral disc
Zhuang Zhu, Qifan Yu, Hanwen Li, et al.
Bioactive Materials (2023) Vol. 28, pp. 167-182
Open Access | Times Cited: 37
Type 2 Diabetes (T2DM) and Parkinson’s Disease (PD): a Mechanistic Approach
S. Sri Sabari, Kiruthika Balasubramani, Mahalaxmi Iyer, et al.
Molecular Neurobiology (2023) Vol. 60, Iss. 8, pp. 4547-4573
Open Access | Times Cited: 35
Metabolic perspective of astrocyte dysfunction in Alzheimer's disease and type 2 diabetes brains
Zheng Shen, Zhengyang Li, Mengting Yu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 158, pp. 114206-114206
Open Access | Times Cited: 33
Important roles of linoleic acid and α-linolenic acid in regulating cognitive impairment and neuropsychiatric issues in metabolic-related dementia
Oh. Yoen Kim, Juhyun Song
Life Sciences (2023) Vol. 337, pp. 122356-122356
Open Access | Times Cited: 28
Akt signaling pathway: a potential therapy for Alzheimer’s disease through glycogen synthase kinase 3 beta inhibition
Joshua Limantoro, Bryan Gervais de Liyis, Jane Carissa Sutedja
The Egyptian Journal of Neurology Psychiatry and Neurosurgery (2023) Vol. 59, Iss. 1
Open Access | Times Cited: 27
Alzheimer’s Disease as Type 3 Diabetes: Understanding the Link and Implications
Mateusz Kciuk, Weronika Kruczkowska, Julia Gałęziewska, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 11955-11955
Open Access | Times Cited: 13
Crosstalk between MiRNAs/lncRNAs and PI3K/AKT signaling pathway in diabetes mellitus: Mechanistic and therapeutic perspectives
Seyed Mohsen Aghaei Zarch
Non-coding RNA Research (2024) Vol. 9, Iss. 2, pp. 486-507
Open Access | Times Cited: 12
The role of PI3K signaling pathway in Alzheimer’s disease
Jingying Pan, Yao Qi, Yankai Wang, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 10
Drugs repurposing in the experimental models of Alzheimer’s disease
Sheer A. Joodi, Weam W. Ibrahim, Mahmoud M. Khattab
Inflammopharmacology (2025)
Open Access | Times Cited: 1
CBD and the 5-HT1A receptor: A medicinal and pharmacological review
Claire Alexander, Jiyoon Jeon, Kyle Nickerson, et al.
Biochemical Pharmacology (2025) Vol. 233, pp. 116742-116742
Closed Access | Times Cited: 1
Ketone production by ketogenic diet and by intermittent fasting has different effects on the gut microbiota and disease progression in an Alzheimer’s disease rat model
Sunmin Park, Ting Zhang, Xuangao Wu, et al.
Journal of Clinical Biochemistry and Nutrition (2020) Vol. 67, Iss. 2, pp. 188-198
Open Access | Times Cited: 70
Role of Insulin Resistance in the Alzheimer's Disease Progression
Thuy Trang Nguyen, Qui Thanh Hoai Ta, Thi Thuy Dung Nguyen, et al.
Neurochemical Research (2020) Vol. 45, Iss. 7, pp. 1481-1491
Closed Access | Times Cited: 69
Role of Insulin in Neurotrauma and Neurodegeneration: A Review
Michael Shaughness, Deanna Acs, Fiona Brabazon, et al.
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 57
Bioactivity of natural biflavonoids in metabolism-related disease and cancer therapies
José C. J. M. D. S. Menezes, Marc Diederich
Pharmacological Research (2021) Vol. 167, pp. 105525-105525
Closed Access | Times Cited: 56
Essential Oils as a Potential Neuroprotective Remedy for Age-Related Neurodegenerative Diseases: A Review
Aswir Abd Rashed, Ahmad Zuhairi Abd Rahman, Devi-Nair Gunasegavan Rathi
Molecules (2021) Vol. 26, Iss. 4, pp. 1107-1107
Open Access | Times Cited: 55
Resveratrol, Metabolic Dysregulation, and Alzheimer’s Disease: Considerations for Neurogenerative Disease
Alex Yang, Ahmed Bagit, Rebecca E. K. MacPherson
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4628-4628
Open Access | Times Cited: 55
Inflammasome NLRP3 Potentially Links Obesity-Associated Low-Grade Systemic Inflammation and Insulin Resistance with Alzheimer’s Disease
Anna Litwiniuk, Wojciech Bik, Małgorzata Kalisz, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5603-5603
Open Access | Times Cited: 44
Akebia saponin D protects hippocampal neurogenesis from microglia-mediated inflammation and ameliorates depressive-like behaviors and cognitive impairment in mice through the PI3K-Akt pathway
Qin Liu, Jinqiang Zhang, Chenghong Xiao, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 35
Alternative role of glucagon-like Peptide-1 receptor agonists in neurodegenerative diseases
Shang‐Der Chen, Yao‐Chung Chuang, Tsu‐Kung Lin, et al.
European Journal of Pharmacology (2022) Vol. 938, pp. 175439-175439
Closed Access | Times Cited: 35
Metformin in Alzheimer’s disease: An overview of potential mechanisms, preclinical and clinical findings
Mohammad Rafi Khezri, Keyvan Yousefi, Negin Mahboubi, et al.
Biochemical Pharmacology (2022) Vol. 197, pp. 114945-114945
Closed Access | Times Cited: 32
Insulin signaling as a therapeutic mechanism of lithium in bipolar disorder
Iain H. Campbell, Harry Campbell, Daniel J. Smıth
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 32
Plasma microRNA vary in association with the progression of Alzheimer's disease
Diane Guévremont, Helen Tsui, Robert G. Knight, et al.
Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 30
Inflammatory bowel disease: an overview of Chinese herbal medicine formula-based treatment
Shuo Yuan, Qi Wang, Jiao Li, et al.
Chinese Medicine (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 30

Scroll to top